Halozyme Therapeutics
HALO
#2112
Rank
NZ$12.79 B
Marketcap
$100.56
Share price
-2.42%
Change (1 day)
58.05%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$2.53 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is NZ$2.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$2.37 B-0.06%
2022-12-31NZ$2.37 B84.82%
2021-12-31NZ$1.28 B133.14%
2020-12-31NZ$0.55 B-7.9%
2019-12-31NZ$0.59 B217.27%
2018-12-31NZ$0.18 B-33.87%
2017-12-31NZ$0.28 B-8.89%
2016-12-31NZ$0.31 B329.5%
2015-12-31NZ$72.81 M14.42%
2014-12-31NZ$63.63 M5.07%
2013-12-31NZ$60.56 M60.15%
2012-12-31NZ$37.81 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$0.38 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$52.49 B 1,968.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.50 B 787.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$112.37 B 4,328.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$42.94 B 1,592.70%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$60.30 B 2,276.82%๐Ÿ‡บ๐Ÿ‡ธ USA